Imperva, Inc.: Hagens Berman Partner Reed Kathrein

Hagens Berman Partner Reed Kathrein: SAN Apr 16, 2014 - Hagens Berman Sobol Shapiro LLP an investor-rights law firm has opened a securities investigation against Imperva, Inc. /quotes/zigman/7245535/delayed /quotes/nls/impv .47% Imperva or the Company following allegations that the company artificially inflated its stock prices, and alerts investors of the June 10, 2014 deadline to file for lead plaintiff in a securities fraud case against the company. Investors who purchased Imperva stock between May 2, 2013 and April 9, 2014 the Class Period may contact Hagens Berman Partner Reed Kathrein, who is leading the firms investigation, by calling 510-725-3000, emailing Imperva@hbsslaw.com or visiting http://hb-securities.com/investigations/Imperva . , according to Market Watch. According to the complaint, Impervas top officers and directors sold $25.9 million worth of their Imperva stock at these inflated prices, selling a large portion days before the company released its preliminary first quarter 2014 financial results. This amount included $11.8 million from the companys CEO and CFO. The complaint filed in the U.S. District Court for the Northern District of California alleges that the data security solutions company violated federal securities laws by issuing misleading and false information to investors about its business and financial results, causing the companys stock price to climb to artificially high levels during the Class Period. During this period of time, the complaint states that Imperva stock reached a high of $65.53 per share on March 6, 2014. (news.financializer.com). As reported in the news.